TransMedics Reports Strong Financial Growth in Q2 2025 with Increased Revenue and New Innovations TransMedics Group, Inc. announces impressive Q2 2025 financial results, highlighting a 38% revenue increase and new innovations in organ transplant therapy.

TransMedics Reports Strong Financial Growth in Q2 2025 with Increased Revenue and New Innovations #United_States #TransMedics #Andover #Organ_Care_System #NOP_Program